Sort
30,917 grants matching “tumor microenvironment”
Core 2: Animal Model and Experimental Therapeutics Core [AMETC]
$253,150Maneesh Jain · University Of Nebraska Medical Center · P01 · FY2020 · CA
Tumor Microenvironment/Angiogenesis Training Grant
$253,138Debabrata Mukhopadhyay · Mayo Clinic Rochester · T32 · FY2013 · CA
Nanoformulations for siRNA Delivery to Ovarian Cancer
$253,113Phillip A Sharp · Massachusetts Institute Of Technology · U54 · FY2014 · CA
Ligand-Directed Targeting in Prostate Cancer Metastasis
$253,102Renata Pasqualini · University Of Tx Md Anderson Can Ctr · P50 · FY2012 · CA
C/EBPβ in bone marrow stromal cell-mediated drug resistance of multiple myeloma
$253,063Gangqing Hu · West Virginia University · P20 · FY2025 · GM
Role of Fibulin-5 in Tumorigenesis and TGF-beta Biology
$253,012William Schiemann · University Of Colorado Denver · R01 · FY2007 · CA
Core 2: Animal Model and Experimental Therapeutics Core [AMETC]
$253,011Maneesh Jain · University Of Nebraska Medical Center · P01 · FY2018 · CA
P2 - Targeting DII4-Notch Signaling in Ovarian Cancer
$252,969Anil K Sood · University Of Tx Md Anderson Can Ctr · P50 · FY2013 · CA
Microenvironmental Transport for Immunotherapy in Pancreatic Cancer
$252,940Jason B Fleming · Methodist Hospital Research Institute · U54 · FY2016 · CA
Ongoing inflammation following chemotherapy induces immunosuppression
$252,910Chuanlin Ding · University Of Louisville · P20 · FY2023 · GM
Tageting BAFF and BAFF-Induced Non-Canonical NF-kB Pathways for Enhancing Mantle
$252,770Jianguo Tao · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2013 · CA
Myeloma-Microenvironment Interaction Dynamics
$252,760University Of Arkansas Med Scis Ltl Rock · R01 · FY2004 · CA
Myeloma-Microenvironment Interaction Dynamics
$252,760University Of Arkansas Med Scis Ltl Rock · R01 · FY2003 · CA
Myeloma-Microenvironment Interaction Dynamics
$252,760University Of Arkansas Med Scis Ltl Rock · R01 · FY2005 · CA
Understanding and addressing sub-optimal responses to CAR T cell therapy for Multiple Myeloma
$252,737Eric L Smith · Dana-Farber Cancer Inst · K08 · FY2023 · CA
Understanding and addressing sub-optimal responses to CAR T cell therapy for Multiple Myeloma
$252,737Eric L Smith · Dana-Farber Cancer Inst · K08 · FY2021 · CA
Understanding and addressing sub-optimal responses to CAR T cell therapy for Multiple Myeloma
$252,737Eric L Smith · Dana-Farber Cancer Inst · K08 · FY2022 · CA
Understanding and addressing sub-optimal responses to CAR T cell therapy for Multiple Myeloma
$252,737Eric L Smith · Dana-Farber Cancer Inst · K08 · FY2020 · CA
Novel oncolytic virotherapy for brain tumors
$252,708Hiroaki Wakimoto · Massachusetts General Hospital · R21 · FY2018 · NS
Defining an Integrated Allostatic Load Index with Immune and Tumor Microenvironment Factors
$252,630Richard R Drake · Medical University Of South Carolina · U54 · FY2017 · MD
Novel CCR2 PET for Pancreatic Cancer Imaging and Prediction of Response to Standard and CCR2-Targeted Therapy
$252,589Farrokh Dehdashti · Washington University · R01 · FY2024 · CA
Tracking Immune Activation by Stress Proteins In Vivo
$252,521Christopher A Pennell · University Of Minnesota · R01 · FY2007 · CA
Murine Neuroblastoma Models for Preclinical Therapeutics
$252,496William A Weiss · University Of California, San Francisco · R01 · FY2014 · CA
Project 2: Microenvironment Modification and Anti-PD1 Immunotherapy of Lymphoma
$252,478George J Weiner · University Of Iowa · P50 · FY2020 · CA
Tracking Immune Activation by Stress Proteins In Vivo
$252,477Christopher A Pennell · University Of Minnesota · R01 · FY2008 · CA